High hexacosanoic acid levels are associated with coronary artery disease

Tetsuro Miyazaki1, Kazunori Shimada1, Makoto Hiki1

  • 1Department of Cardiovascular Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

Atherosclerosis
|February 18, 2014
PubMed

Insights

High levels of hexacosanoic acid (C26:0), a saturated very long chain fatty acid (VLCFA), are linked to coronary artery disease (CAD). This finding suggests C26:0 may serve as an independent marker for CAD risk.

Area of Science:

  • Cardiovascular Science
  • Metabolic Health
  • Biomarker Discovery

Background:

  • Saturated very long chain fatty acids (VLCFAs) are associated with coronary risk factors like metabolic syndrome (MS), atherogenic lipoproteins, and inflammation.
  • The direct relationship between circulating saturated VLCFA levels and coronary artery disease (CAD) has not been clearly established.

Purpose of the Study:

  • To investigate the association between circulating hexacosanoic acid (C26:0) levels and the presence of coronary artery disease (CAD).
  • To determine if C26:0 serves as an independent risk marker for CAD.

Main Methods:

  • A case-control study involving 100 CAD patients and 40 healthy controls matched for age, gender, and BMI.
  • Whole blood levels of hexacosanoic acid (C26:0) were quantified using gas-liquid chromatography mass spectrometry.

Main Results:

  • C26:0 levels were significantly higher in CAD patients compared to controls (P=0.01).
  • C26:0 levels positively correlated with BMI, triglyceride levels, and hypertension.
  • Elevated C26:0 levels in CAD patients were observed independently of metabolic syndrome (MS) and served as an independent marker for CAD in multivariate analysis.

Conclusions:

  • High whole blood C26:0 levels may represent an independent biomarker for identifying individuals at risk of coronary artery disease (CAD).
  • Further research into C26:0 as a diagnostic or prognostic tool for CAD is warranted.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
854
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
5.5K